Back to results
US 2017/0320947 A1Published application
Heterodimeric antibodies that bind cd3 and psma
AssigneeXencor, Inc.
InventorsGregory Moore, John Desjarlais, Seung Chu
Life of this patent
Estimating the term…
Abstract
The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.
Claims24
1-55. (canceled)
A composition comprising a prostate membrane antigen binding domain (PSMA) binding domain, said PSMA binding domain comprising:
- a) a heavy variable domain having amino acid sequence of SEQ ID NO:
- 110;
- and
- b) a variable light domain having amino acid sequence of SEQ ID NO:
- 106
2 more elements
A heterodimeric antibody comprising:
- a) a first monomer comprising:
- i) a first Fc domain;
- and
- ii) an anti-CD3 scFv comprising a first heavy variable domain, an scFv linker and a first variable light domain;
- wherein said scFv is covalently attached to the N-terminus of said Fc domain using a domain linker;
- b) a second monomer comprising a heavy chain comprising:
- i) a second heavy variable domain;
- and
- ii) a heavy constant domain comprising a second Fc domain;
- and
- c) a light chain comprising a second variable light domain and a constant light domain;
- wherein said second heavy variable domain comprises a vhCDR1 having SEQ ID NO:
- 111, a vhCDR2 having SEQ ID NO:
- 112, and a vhCDR3 having SEQ ID NO:
- 113,
- and said second variable light domain comprises a vlCDR1 having SEQ ID NO:
- 107, a vlCDR2 having SEQ ID NO:
- 108, and a vlCDR3 having SEQ ID NO:
- 109, and wherein said second heavy variable domain and said second variable light domain bind PSMA.
16 more elements
Dependencies are inferred from the claim text.